He has held numerous administrative positions at UNMC, including vice chairman of Pathology and Microbiology, director of Surgical Pathology, director of Cytopathology, associate dean for Academic Affairs and interim dean of Medicine.
In January 2007, UNMC's intellectual property office merged with UNeMed, and Linder was appointed president of the expanded operation.
[11] He is a member and has had leadership positions with many medical organizations, and active in the development of the Interactive Center of the U.S.-Canadian division of the International Academy of Pathology.
[12] He holds numerous patents, and his academic interests include the application of technology in medical diagnostics, including immunochemistry, molecular diagnostics, computer-aided instruction, digital imaging in pathology, and the use of automated techniques in cytopathology and hematology.
The company was later acquired by the Roche Diagnostics,[14] in 2013, and Linder stayed on, until 2015, and there developed a hematology analyzer.
In 2015, recognizing accomplishments in laboratory medicine and technology transfer, he was inducted as a fellow of the National Academy of Inventors.
[21] In 2005, he was presented with the American Society of Clinical Pathologists' "Israel Davidsohn Award for Distinguished Service.
"[4] He received the Iowa State University Distinguished Alumni Award, in 2020,[22] and he and Karen Linder were inducted into the Omaha Business Hall of Fame.